Written by Denis Rezendes
Caveat Emptor (Buyer Beware)
August 16, 2018 |
As a Tactical ETF Strategist, we consider ourselves fairly qualified to navigate the exchange traded product (ETP) universe. That being said, there’s one place even we won’t go. To pull a quote directly from our presentation: no margin, leverage, or shorting. We believe that this subset of the ETF universe is far more trouble than it’s worth for investors, experienced and unexperienced alike.
The last year has provided us with a wonderful case study in the form of ETPs that track the Cboe Volatility Index (VIX). No, this isn’t another piece about the short VIX ETPs which, rather spectacularly, lost nearly all of their value overnight in February 2018.¹ Instead, we’ll look at what happened to people who were on the other side of the trade. As we sit here today, the VIX is hovering around 14. While the VIX is not quite back to the exceedingly low levels it saw prior to the increased volatility we saw in the spring, it’s close enough for us to reflect.
Before we get started it’s worth pointing out that plenty of ink has been spilled on this subject. While we don’t necessarily have a unique opinion to offer we believe investors can only benefit from repetition of the same cautionary tale. VIX ETPs are designed for trading and, as we will show, are not suitable to be held for any extended period of time.
Best Case Scenario
I’ll start with the best case scenario and then move onto something a little more realistic. Let’s say you finally capitulated on January 1, 2018. Volatility is too low, it must go higher. You were certainly correct in the short term; by February 8th the VIX was up over 200%. If you bought a prominent VIX ETP (1x VIX) your position was up around 100% by the same day. Not quite what you signed up for, but not bad either. Now let’s fast forward to today.* The VIX is up nearly 34% year-to-date through 8/13/2018 and 1x VIX is up nearly 14%. Sure, that’s acceptable but remember we said this was a best case scenario.
Now let’s take a look at the numbers if instead you bought an ETP that is designed to double the movements of the VIX (2x VIX).** On February 8th you were up about 140%, again acceptable but below expectations, and then fast forward to today and you are down 32%…
Now for the more realistic scenario.
It’s May 1st 2017 and you finally capitulated. Volatility is too low, it must go higher. By the time 2018 rolls around, the VIX is flat but the 1x VIX is down roughly 50% and the 2x VIX is down roughly 75%. The same +200% increase in the VIX during February of 2018 barely gets you back to even on 1x VIX and 2x VIX is still down nearly 50%. Fast forward to today and, despite a 46% increase in the VIX, 1x VIX is down 45% and 2x VIX is down 87%.
Back to Reality
So why all the carnage? A book could be written on the topic but to put it simply, when you buy a VIX ETP you’re buying a one day insurance contract. This insurance is not only expensive, but it’s also very unlikely to pay off. When you hold a VIX ETP you’re implicitly renewing this one day insurance contract every single day. Over time this depletes your capital and although the insurance still provides the same coverage per dollar purchased the aggregate amount of insurance that you can afford gets smaller and smaller.
Oh, and I forgot to mention. In the best case scenario 1x VIX was down nearly 8% and 2x VIX nearly 15% two weeks into January. What’s the chance you actually held it all the way until February?
The moral of the story? VIX ETFs are not for the faint of heart and are often misunderstood. Investors could avoid a lot of pain by staying away from them, as well as from margin, leverage and shorting.
Sources and Disclosures:
¹Levine, Matt. “Inverse Volatility Products Almost Worked.” Bloomberg.com, Bloomberg, 9 Feb. 2018
*If you’re thinking “fast forward to today? I would have sold the top!” stop it and be honest with yourself. You probably would have bought more.- Denis Rezendes, Beaumont Capital Management
**Let’s be real. Who only buys 1x when 2x is available? – Denis Rezendes, Beaumont Capital Management
Copyright © 2018 Beaumont Financial Partners, LLC DBA Beaumont Capital Management (BCM). All rights reserved.
The VIX® is used by stock and options traders to gauge the market’s “anxiety” or “fear” level. It is a mathematical measure of how much the market thinks the S&P 500 Index option, or SPX, will fluctuate over the next 12 months, based upon an analysis of the difference between current SPX put and call option prices. The CBOE Volatility Index (VIX) is a registered trademark of Chicago Board Options Exchange, Incorporated. All index names of the Barclays indices are trademarks of Barclays Bank PLC.
The CBOE Volatility Index® (VIX)® is based on the S&P 500® Index (SPX), the core index for U.S. equities, and estimates expected volatility by averaging the weighted prices of SPX puts and calls over a wide range of strike prices. Indices are not managed and do not incur fees or expenses. ETF performance shown is net of the ETF’s fees.
This material is provided for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any security or financial instrument, nor should it be construed as financial or investment advice, or as a recommendation.
Past performance is no guarantee of future results. Diversification does not ensure a profit or guarantee against a loss. As with all investments, there are associated inherent risks.
The views and opinions expressed throughout this piece are those of our Research Analyst at the time of this post. The opinions or outlooks may change over time with changing market conditions or other relevant variables.
The information presented in this report is based on data obtained from third party sources. Although it is believed to be accurate, no representation or warranty is made as to its accuracy or completeness.
Popular Posts
- Financial Sector Breakout, Record Setting Trade Deficits, Underwhelming Regional Fed Reports
- BCM 3Q19 Market Commentary: Blinking Yellow Lights
- Unemployment, Unbothered Equities, and the Uncertain Path Forward
- BCM 2Q 18 Market Commentary
- BCM 4Q19 Market Commentary: Will the Next Decade Look Anything Like the Last Two?